Zhejiang Hisun Pharmaceutical Co., Ltd. (600267) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Zhejiang Hisun Pharmaceutical Co., Ltd.

Why is Zhejiang Hisun Pharmaceutical Co., Ltd. ?

With ROE of 5.96%, it has a attractive valuation with a 1.47 Price to Book Value

Over the past year, while the stock has generated a return of 17.56%, its profits have risen by 631.2% ; the PEG ratio of the company is 0
At the current price, the company has a high dividend yield of 2.1

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to Zhejiang Hisun Pharmaceutical Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Zhejiang Hisun Pharmaceutical Co., Ltd. for you?

Medium Risk, High Return

Absolute

Risk Adjusted

Volatility

Zhejiang Hisun Pharmaceutical Co., Ltd.

14.15%

1.15

28.95%

China Shanghai Composite

15.17%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-2.03%

EBIT Growth (5y)

22.32%

EBIT to Interest (avg)

2.76

Debt to EBITDA (avg)

3.34

Net Debt to Equity (avg)

0.35

Sales to Capital Employed (avg)

0.76

Tax Ratio

21.59%

Dividend Payout Ratio

40.74%

Pledged Shares

Institutional Holding

ROCE (avg)

5.18%

ROE (avg)

6.61%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.47

EV to EBIT

19.82

EV to EBITDA

8.27

EV to Capital Employed

1.37

EV to Sales

1.52

PEG Ratio

0.04

Dividend Yield

2.06%

ROCE (Latest)

6.91%

ROE (Latest)

5.96%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 2,315.78 MM

DEBT-EQUITY RATIO (HY)

Lowest at 25.3 %

RAW MATERIAL COST(Y)

Fallen by -21.5% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 4.43 times

NET SALES(Q)

Highest at CNY 2,672.46 MM

-4What is not working for the Company

INTEREST COVERAGE RATIO(Q)

Lowest at 972.29

OPERATING PROFIT(Q)

Lowest at CNY 230.9 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 8.64 %

Here's what is working for Zhejiang Hisun Pharmaceutical Co., Ltd.

Debt-Equity Ratio

Lowest at 25.3 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Operating Cash Flow

Highest at CNY 2,315.78 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Sales

Highest at CNY 2,672.46 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Debtors Turnover Ratio

Highest at 4.43 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -21.5% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Zhejiang Hisun Pharmaceutical Co., Ltd.

Interest Coverage Ratio

Lowest at 972.29

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Profit

Lowest at CNY 230.9 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 8.64 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales